- Home
- TNGX vs FBK Comparison
TNGX vs FBK Comparison
Compare TNGX & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | FBK |
|---|---|---|
| Founded | 2014 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.8B |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TNGX | FBK |
|---|---|---|
| Price | $31.47 | $55.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $21.78 | ★ $64.50 |
| AVG Volume (30 Days) | ★ 5.5M | 329.0K |
| Earning Date | 05-08-2026 | 04-13-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | ★ 26.89 | N/A |
| EPS | N/A | ★ 1.10 |
| Revenue | ★ $62,384,000.00 | N/A |
| Revenue This Year | N/A | $41.72 |
| Revenue Next Year | N/A | $7.21 |
| P/E Ratio | ★ N/A | $50.45 |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $4.80 | $45.10 |
| 52 Week High | $34.39 | $62.37 |
Technical Indicators
Market Signals| Indicator | TNGX | FBK |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | 61.04 |
| Support Level | $19.74 | $55.31 |
| Resistance Level | $34.39 | $56.02 |
| Average True Range (ATR) | 2.49 | 1.08 |
| MACD | -0.05 | 0.20 |
| Stochastic Oscillator | 48.50 | 78.44 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.